Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation, a Multicenter Study
Status: Recruiting
Location: See all (15) locations...
Intervention Type: Procedure
Study Type: Observational
SUMMARY
INTERLIVER is a prospective observational study of the relationship of the molecular phenotype of 300 liver transplant biopsies to the histologic phenotype and the clinical features and outcomes. A segment of a biopsy performed as standard-of-care for indications, or by center protocol, will be used for gene expression study.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• biopsy for clinical indications
Locations
United States
California
University of California San Francisco, Transplant Research Unit
COMPLETED
San Francisco
Illinois
Northwestern Memorial Hospital
COMPLETED
Chicago
Maryland
University of Maryland School of Medicine
COMPLETED
Baltimore
Michigan
Henry Ford Transplant Institute
RECRUITING
Detroit
Tennessee
Vanderbilt University Medical Center, Vanderbilt Transplant Center
WITHDRAWN
Nashville
Texas
Baylor University Medical Center, Annette C. and Harold C. Simmons Transplant Institute
COMPLETED
Dallas
Virginia
Transplant Surgery, VCU Medical Center
COMPLETED
Richmond
Washington
Division of Transplant Surgery, University of Washington
COMPLETED
Seattle
Other Locations
Australia
Centenary Institute of Cancer Medicine & Cell Biology, Royal Prince Alfred Hospital
COMPLETED
Camperdown
Canada
University of Alberta, Laboratory Medicine and Pathology
COMPLETED
Edmonton
Poland
Dep. of Nephrology, Transplantation & Internal Med., Samodzielny Publiczny Szpital Kliniczny im. A. Mieleckiego
COMPLETED
Katowice
Independent Public Composite Regional Hospital
COMPLETED
Szczecin
Warsaw Medical University, Independent Public Clinical Hospital
COMPLETED
Warsaw
Warsaw Medical University, Jesus the Child Clinical Hospital
COMPLETED
Warsaw
United Kingdom
Institute for Liver Science, King's College London
COMPLETED
London
Contact Information
Primary
Konrad S Famulski, PhD
konrad@ualberta.ca
1 780 492 1725
Backup
Robert Polakowski, PhD
polakows@ualberta.ca
1 780 492 5091
Time Frame
Start Date: 2017-12-19
Estimated Completion Date: 2026-12
Participants
Target number of participants: 300
Authors
Vince Bain, Sandy Feng, Seth J Karp, Amar Gupta, Martin I Montenovo, Roman Perri, Goran Klintmalm, Stephen Gray, Marek Pacholczyk, Alberto Sanchez-Fueyo, Samir Zeair, Maciej Krasnodebski, Marta Marta Wawrzynowicz-Syczewska, Michal Grat, Grzegorz Piecha, Krzysztof Zieniewicz, Agnieszka Perkowska-Ptasinska, Aducio Thiesen, Geoffrey McCaughan
Related Therapeutic Areas
Sponsors
Leads: University of Alberta